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| \ J  | Dioxins bioaccumulate in adipose tissue and can be found in most persons. 
j\ J | Because dioxins cause cancer in some animals, human exposure is a concern. 
j \ / |  Chloracne is the only overt clinical sign of dioxin exposure in humans.
This monograph is one in a series of self-instructional publications designed to increase the primary care 
provider's knowledge of hazardous substances in the environment and to aid in the evaluation of potentially 
exposed patients. The Agency for Toxic Substances and Disease Registry (ATSDR) and the Centers for Disease 
Control (CDC) designate this continuing medical education activity for 1 credit hour in Category 1 of the 
Physician's Recognition Award of the American Medical Association and 0.1 continuing education units for other 
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How to use this issue...
This issue begins with a composite case study that describes a realistic encounter with a patient. This description 
is followed by a pretest. The case study is further developed through Challenge questions at the end of each 
section. To fully benefit from this monograph, readers are urged to answer each question when it is presented. 
(Answers to the Pretest and Challenge questions are found on page 16.) The monograph ends with a posttest, 
which can be submitted to ATSDR for continuing medical education (CME) credit or continuing education units 
(CEU). See page 17-19 for further instructions on how to receive these credits.
The objectives of this monograph on dioxin are to help you:
□  Realize why dioxin Is an acute and chronic health hazard
□  Understand the known factors contributing to dioxin toxicity
□  Assess a patient's environmental or occupational exposure to dioxin
□  Effectively evaluate and manage dioxin-exposed patients
□  Utilize a variety of sources to locate further information on dioxin
This issue is prepared with the assistance of those who share a common concern for physician education, public 
health, and the environment, including the following organizations: American Academy of Family Physicians (AAFP), 
American Academy of Pediatrics (AAP), American College of Emergency Physicians (ACEP), American College of 
Occupational and Environmental Medicine (ACOEM), American Medical Association (AMA), Association of State and 
Territorial Health Officials (ASTHO), and the Society of Teachers of Family Medicine (STFM). Final responsibility for 
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Dioxin toxicity
A 5-year-old boy with a vesicular facial rash one day after contact with an herbicide
A 5-year-old boy is brought to your office after acute onset of a rash on his face and arms. The rash consists of 
small blisters with surrounding erythema, which the patient states itch and burn. The boy's mother says she 
noticed the rash on her son’s face last evening, and by morning it had spread to both arms. The child also 
complains of a headache and stomachache that began early this morning. His temperature is normal.
Further history reveals that the patient and his family moved to this Midwest rural area 2 years ago; their farm is 
adjacent to a wooded area. Two days ago, workmen from a utility company sprayed beneath the high-voltage 
power lines that traverse the back edge of the property where the children frequently play during the summer. On 
questioning, the workmen told the mother they were using an herbicide, but assured her the area would be safe 
for the children in a few hou rs. The mother asks you if the defoliant cou Id have contained diox ins, and, if so, whether 
her child has been affected. Her concern stems from what she has heard about alleged effects of Agent Orange 
on Vietnam veterans.
Medical history and chart review reveal the child has had no major illnesses. He has had a normal pattern of growth 
and development, both physical and psychosocial. Immunizations are up to date.
iPretest
(a) What further questions would you ask while taking the medical history?
(b) On what aspect of the boy’s physical examination should you focus to address the mother's concern?
(c) What laboratory tests are appropriate to aid in the diagnosis?
(d) Are dioxins likely to be the cause of the boy's rash? Explain.
Answers to the Pretest are incorporated in Challenge answers (6) through (10) on page16.
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Exposure Pathways
□  The general population’s 
principal route of dioxin 
exposure Is through the 
food chain.
□  Other minor dioxin sources 
are diesel exhaust, chlorine- 
bleached paper products, 
and incineration gases.
Dioxins and furans are terms applied to polychlorinated dibenzo-p- 
dioxins and polychlorinated dibenzofurans (Figure 1). They are be­
lieved to produce similar health effects and are known to coexist as 
unwanted contaminants in various materials. Because 2,3,7,8- 
tetrachlorodibenzo-p-dioxin (TCDD) is the most thoroughly studied 
and most toxic of the 75 dioxin isomers, the term TCDD is used 
interchangeably with dioxins throughout this monograph. As a pure 
solid, TCDD is colorless, odorless, lipid-soluble, and only sparingly 
soluble in water.




Dioxins, as well asfurans, have received much media attention inthe 
past few decades and hence have become a public concern. 
Dioxins’ reputation as extremely toxic is based primarily on tests 
performed on guinea pigs, the most dioxin-sensitive mammalian 
species. By comparison, the hamster is 5000 to 10,000 times more 
resistant in similar toxicity tests. Extrapolation to humans from data 
based on animal studies is difficult because species vary widely in 
their sensitivity to dioxins and human risk assessment models are 
uncertain.
Several human populations exposed to dioxin-contaminated com­
pounds have been studied extensively for health effects. Some Vi­
etnam veterans were potentially exposed to dioxins through the 
military use of the defoliant Agent Orange (a mixture of 2,4,5-trichlo- 
rophenoxyacetic acid [2,4,5-T] and 2,4-dichlorophenoxyacetic acid 
[2,4-D] contaminated with TCDD). Several areas of the United 
States have been contaminated as a result of industrial discharges 
or spraying of dirt roads with dioxin-contaminated waste oils. Three 
areas that have received notoriety are Love Canal in Niagara Falls, 
New York; Times Beach, Missouri; and Newark, New Jersey. The 
most highly publicized accident affecting a residential population 
was an explosion at a chemical plant that resulted in an airborne 
discharge of dioxins over Seveso, Italy, in 1976. More than 37,000 
people lived in an area that may have been contaminated by dioxins. 
In all cases, there were no deaths from acute poisoning, and con­
comitant exposure to other toxic substances may have contributed 
to the effects that were observed.
Dioxins are formed during the production of many chlorinated 
organic solvents, hexachlorophene, and the herbicide 2,4,5-T. 
Emissions from coal-burning power plants, exhaust from diesel 
engines, and the incomplete burning of wastes containing chlorine, 
such as PVC plastic form both dioxins and furans; they are also 
naturally produced in small amounts by volcanoes and forest fires. 
In nature, dioxins are found adsorbed on air and soil particles. TCDD 
concentrations in water and on vegetation are generally below 
present detection limits.
Extremely small quantities of dioxins are found nearly everywhere in 
the developed world. Minute amounts of TCDD have been detected 
in paper pulp, formed when chlorine is added during the bleaching 
process. TCDD reportedly has been leached from milk cartons and 
from coffee filters (less than 50 parts per trillion [ppt]). The amount 
of dioxins detected in paper-based personal care products such as 
disposable diapers, facial or toilet tissue, and paper towels is 
considered insignificant.
Because dioxins bioaccumulate in the food chain, the major route of 
human exposure is through food, especially fish, meat, and dairy
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products. It has been estimated that food accounts for 98% of total 
adult exposures. TCDD has been detected in fish from Saginaw Bay, 
contaminated sections of the Great Lakes, and some Michigan 
rivers, although levels in both the water andf ish have decreased over 
time.
Use of products known orthought to be contaminated by dioxins and 
furans has been significantly restricted in the last few decades. The 
U.S. Environmental Protection Agency (EPA) has removed the 
herbicide 2,4,5-T from the commercial market, and heat-transfer 
agents using polychlorinated biphenyls (PCBs), which form dioxins 
during combustion, are being phased out of production and use.
Who's at Risk
Workers In the chemical 
Industry may have increased 
likelihood of exposure.
Overt clinical effects from 
dioxin exposure have been 
seen primarily after major 
industrial accidents involv­
ing these compounds.
Fetuses and nursing infants 
may be at increased risk of 
dioxin exposure if the 
mothers have been exposed.
Dioxins are no longer manufactured in the United States, except for 
small amounts used for scientific research. Nevertheless, some 
workers may encounter dioxins as contaminants in certain industrial 
processes such as the manufacture of chlorinated herbicides, ger­
micides, and organic solvents. Firefighters and cleanup crews 
involved with capacitor or transformer fires and hazardous waste 
accidents may also be exposed to dioxins through dermal absorption 
or inhalation. Municipal and waste incinerator workers may encoun­
ter dioxins in smoke, gases, or fly ash formed during combustion 
processes. Major industrial accidents have been the source of most 
overt clinical effects from dioxins.
Because TCDD crosses the placenta and accumulates in breast 
milk, fetuses and nursing infants of contaminated mothers are 
potentially at increased risk of exposure. Ingestion of contaminated 
soil due to pica or normal hand-to-mouth activities may contribute to 
a child’s dioxin body burden. No cases of dioxin toxicity have been 




(2) Would you consider the patient described in the case study at increased risk from dioxin exposure ? 
Explain.
Biologic Fate
Dioxins enter the body by ingestion, inhalation, and dermal absorp­
tion. In humans, the following percentages of total absorption have 
been reported for various exposure routes: inhalation, 25% to 29%; 
ingestion of contaminated soil, 20% to 26%; and ingestion of 
contaminated fish, 50% to 80%. Skin was found to absorb up to 3% 
of the dioxin in contaminated soil.
The metabolic pathway of TCDD for humans has not been estab­
lished. TCDD orally administered to animals is metabolized rela­
tively slowly, but once metabolites are formed, they are rapidly 
excreted in the urine and bile. Metabolism is primarily by hepatic 
detoxification, with the major metabolites consisting of hydroxylated 
or methoxylated TCDD derivatives, which are then excreted as 
glucuronide and sulfate conjugates. Unabsorbed TCDD is excreted 
through direct elimination in the feces. Because of the lipophilic 
nature of milk, nursing females decrease their body burden of TCDD 
through lactation. Dioxins distribute to organs according to lipid 
content and readily accumulate in body fat. In the general popula­
tion, the background level of TCDD in adipose tissue may be as high 
as 20 ppt.
The half-life of TCDD ranges from several hours (on the surface of 
plants) to 7.1 years (in human serum and adipose tissue). On the 
soil’s surface, where TCDD undergoes photodegradation when 
exposed to ultraviolet light, the half-life is 1 to 3 years. Beneath the 
soil’s surface, the half-life of TCDD can be over 10 years.
Dioxins and furans accumulate 
In adipose tissue.
In animals, the major routes of 
absorbed TCDD elimination are 
through lactation and excre­
tion of urine and bile.
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(3) Assuming the utility company mentioned in the case study sprayed the area with a dioxin-containing 
herbicide, when will it be safe for the children to return to the area to play?
Physiologic Effects
Only two effects of dioxln ex­
posure have been confirmed 
In humans: chloracne and 
transient mild hepatotoxicity.
Dioxins are very toxic to some animal species, but the evidence for 
corresponding toxicity in humans has not been established. No 
deaths due to systemic dioxin toxicity in humans have been reported. 
Only two clinical effects have been repeatedly observed in exposed 
populations: chloracne and transient hepatic effects. Soft-tissue 
sarcomas, lymphomas, peripheral neuropathy, birth defects, and re­
productive effects have been studied but remain unconfirmed. 
Because human dioxin exposure always involves mixed exposures, 
the specific effects of dioxin are difficult to ascertain.
In some animals, TCDD is a potent carcinogen and causes repro­
ductive effects and birth defects. TCDD’s toxicity also appears in 
animals as pathologic effects in the liver, peripheral nerves, hema­
topoietic and reticuloendothelial systems, and skin. Acute toxicity 
develops after a latent period of 7 to 10 days, after which the animals 
experience a rapid wasting syndrome not seen in humans.
Dermatologic Effects
□  Chloracne Is a hallmark of Acneform lesions may appear as early as 1 to 3 weeks after dioxin
dioxin toxicity in humans and exposure. The lesions are small, pale yellow cysts, which arise from 
can persist for years after altered differentiation of acinar sebaceous basal cells into ker-
exposure ceases. atinocytes. The lesions primarily involve the face, especially the
periorbital, temporal, and malar areas, as well as the upper body. 
Most cases of chloracne resolve in 1 to 3 years; one case has been 
reported to persist for as long as 32 years. Although TCDD is one 
of the most potent acne-producing agents, chloracne can also be
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caused by chloro- and bromonaphthalenes, polychlorinated and 
polybromlnated biphenyls (PCBs, PBBs), pentachlorophenol, and 
tetrachlorobenzene.
Chloracne is the only overt effect of dioxin exposure in human 
populations; however, the absence of this effect does not rule out 
dioxin exposure. There is no acceptable dose-response model for 
chloracne in exposed human populations. It may develop weeks or 
months after exposure and may be dependent upon individual 
predisposition. It can result from inhalation, ingestion, or dermal 
contact and may indicate systemic toxicity.
Six workers who developed chloracne and other illnesses after an 
industrial accident in Germany had an estimated mean TCDD body 
burden shortly after the accident of 44 micrograms (ng) with a range 
of 9.7 to 124 |j.g. Based on this data, researchers believe that a body 
burden of 9.7 |ag as measured in adipose tissue may be the lowest 
observable adverse effect level for TCDD-related chloracne in 
humans. Thirty-two years after exposure, these workers still had 
detectable levels of TCDD in adipose tissue, and one still had 
chloracne.
In addition to chloracne, other reported dermal effects include 
hyperpigmentation, hirsutism, increased skin fragility, and vesicular 
eruptions on exposed areas of the skin. Concomitant exposure to 
other agents, however, may have contributed to these effects.
Neurologic Effects
Although dioxins have produced neurotoxic results in laboratory 
animals, data from human studies have been inconsistent and 
inconclusive. Peripheral nervous system involvement was studied 
6 years after the Seveso accident in 152 victims with chloracne. No 
case of peripheral neuropathy was found; however, subclinical 
peripheral nerve impairment was reported in 16 victims. A study of 
railroad workers exposed to TCDD during cleanup of a tank car spill 
reported that 43 of 45 workers had findings suggestive of peripheral 
neuropathy 6 years after exposure, but the validity of the study has 
been questioned and numerous other epidemiologic studies have 
found no evidence of neurologic impairment due to dioxin exposure.
Hepatic Effects
Although hepatotoxicity has been observed in a variety of animal 
species, there is no evidence that TCDD causes long-term hepato­
toxicity in humans. Some studies have shown a transient increase 
in liver enzymes without clinical disease. A study of Seveso children 
potentially exposed to TCDD revealed hepatomegaly and slightly
□  Human epidemiologic data 
are inconsistent regarding 
TCDD’s neurotoxic effects.
□  Persons exposed to dioxin 
contaminated agents had 




elevated serum levels of GGTP (GGT) and SGPT (ALT); however, 
no apparent liver function impairment was found, and the enzyme 
levels subsequently returned to normal. Studies of liver function in 
people in the Times Beach, Missouri, incident also suggested sub- 
clinical hepatic effects. Epidemiologic studies of TCDD-exposed 
workers, however, have shown no difference in serum levels of 
hepatic enzymes compared with those of matched controls.
Evidence Is lacking that 
TCDD Is a reproductive 
toxicant in humans.
Reproductive and Developmental Effects
Studies of Vietnam sen/icemen possibly exposed to Agent Orange 
revealed no overall increase of debilitating birth defects in progeny. 
A study of the Missouri incident encompassing 410 births reported 
no statistically significant increase in risk ratios for infant, fetal, and 
perinatal death, low birth weight, or for several subcategories of birth 
defects. Studies of the Seveso area have also failed to demonstrate 
increased risk of birth defects due to dioxin exposure.
Numerous reproductive and developmental effects have been noted 
in animals exposed to dioxins. These effects include spontaneous 
abortions in the Rhesus monkey and birth defects in a number of 
other mammalian species.
Carcinogenic Effects
TCDD carcinogenicity In ani­
mals Is well established; 
however, human epidemiol­
ogic data are Inconclusive.
EPA and NIOSH consider 
TCDD alone to be a probable 
human carcinogen, and a 
“cancer promoter” in con­
junction with certain other 
chemicals.
Although evidence for human carcinogenicity is inconclusive, TCDD 
is irrefutably an animal carcinogen. The exact mechanisms of action 
are unknown; therefore extrapolation from animal studies to humans 
is impossible. Before TCDD's potential human carcinogenic capa­
bilities can be determined, long-term epidemiologic studies in hu­
mans are necessary and concomitant exposures must be further 
defined.
Much of the research in humans has focused on TCDD's ability to 
induce soft-tissue sarcomas. Epidemiologic studies have produced 
conflicting results. A study of Swedish workers potentially exposed 
to TCDD-containing phenoxyacetic acid herbicides indicates an as­
sociation between herbicide exposure soft-tissue sarcomas at vari­
ous sites, stomach cancers, and lymphomas. This study was 
criticized for bias recall, and results of similar research in Finland and 
New Zealand refute the Swedish study. Of the more than 200 
workers exposed to dioxin in a plant explosion in Nitro, West Virginia 
in 1949,122 developed chloracne. However, no excess deaths due 
to cancer were found among the workers 30 years afterthe incident.
EPA and the National Institute of Occupational Safety and Health 
(NIOSH) consider TCDD to be a “cancer promoter” in conjunction 
with certain other chemicals. NIOSH classifies TCDD as a "potential
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occupational carcinogen." EPA considers TCDD to be a probable 
human carcinogen. The category of "probable human carcinogen" 
indicates that EPA considers animal evidence of carcinogenicity 
"sufficient” and human evidence "inadequate."
Immunotoxic Effects
Abundant animal data indicate that immunotoxicity may be one of the 
most sensitive toxicologic outcomes forTCDD. Investigations of this 
endpoint in humans are limited; thus, the importance of TCDD- 
induced immunotoxicity in humans cannot be evaluated and assess­
ing this endpoint in patients has no clinical value.
Assessment of immunologic 
effects in TCDD-exposed pa­
tients has no clinical value.
Chattmg
(4) If the child described in the case study had been exposed to dioxln, what health effects might he 
experience?
(5) What is the child's risk of developing cancer from the exposure described in the case study?
9
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Clinical Evaluation
□  A detailed history and physi­
cal examination are needed 
to discover all possible 
sources of exposure.
□  Chloracne and elevated liver 
enzymes may be noted In 
persons with dioxin toxicity.
□  Blood and adipose tissue 
tests for TCDD levels are not 
recommended unless the 
exposure Is massive.
History and Physical Examination
Because dioxins are extremely persistent and bioaccumulate in the 
food chain, a patient's entire exposure history must be taken into 
account. If exposure to dioxins is suspected, the history should 
include the following:
past and present occupational duties
military service in Vietnam involving handling or spraying of herbicides 
proximity of residence or work to waste sites or incinerators 
contact with herbicides, fungicides, and germicides 
dietary composition and habits 
history of breast-feeding
In the physical examination, the clinician should review all systems, 
with particular attention to the skin, liver, and peripheral nervous 
system. Discovery of a person with dioxin toxicity should suggest 
that others, such as coworkers, friends, or family members, may 
have been exposed similarly.
Signs and Symptoms
The onset of symptoms after acute exposure to TCDD-containing 
substances can take days to weeks. Symptoms reported by hazard­
ous waste cleanup crews who later developed chloracne were skin, 
eye, and respiratory tract irritation; headache; dizziness; and nau­
sea. Other reported symptoms of exposure to TCDD-contaminated 
compounds include loss of appetite, weight loss, loss of libido, 
sensory changes, severe fatigue, pain in the abdomen and extremi­
ties, memory impairment, uncharacteristic bouts of anger, and 
insomnia. Many of these signs and symptoms are nonspecific and 
commonly observed with exposure to other chemicals. Since 
exposure to TCDD always involves mixed exposures, it is impossible 
to state with certainty that dioxins caused these effects.
Laboratory Tests 
Direct Biologic Indicators
Adipose tissue and blood serum analyzed for the presence of TCDD 
by gas chromatography-mass spectrometry (GC-MS), can be quan­
tified to100 parts per quadrillion. Some researchers believe that 
serum levels correlate with adipose tissue levels in persons with 
long-term exposure. However, analyses of serum orf at TCDD levels
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by GC-MS are expensive and time-consuming; therefore, unless 
exposure has been massive, they are not recommended. Levels of 
20 ppt in adipose tissue have been measured in persons with no 
known exposure to TCDD. In 50 persons exposed in the Missouri 
incident, the mean ratio of the TCDD level in adipose tissue to that 
in serum was 1.09 after adjusting both samples for lipid content. 
Some of the exposed people in the Seveso, Italy, accident had 
TCDD levels a thousand times greater than the average found in the 
general unexposed population and did not experience illness.
Indirect Biologic Indicators
Chloracne may be an indicator of dioxin toxicity, although its ab­
sence does not necessarily rule out exposure. New cases should be 
reported to local or state public health authorities. In the absence of 
chloracne, liver function tests may be the most sensitive indicator of 
dioxin exposure. This measure, however, is nonspecific, and normal 
results do not rule out significant exposure or elevated body burden.
Cases of chloracne should 
be reported to public health 
authorities.
Ctaftengi
(6) What issues should you address In obtaining the medical history of the child described in the case 
study?
(7) What would be the focus of the physical examination if dioxin exposure were a possibility?
(8) What laboratory tests, if any, would you use to evaluate this child?




□  No antidote for dioxin Treatment of chronic exposure to dioxin-containing agents is primar-
toxicity is known; sympto- ily supportive, and depends on the agent involved and the presenting
matic and supportive care is sjgns ancj symptoms. It is most important to remove the patient from 
the only therapy. the source of exposure. Chloracne is often refractory and unrespon­
sive to common acne treatments. Long-term topical treatment with 
dilute retinoic acid and administration of tetracycline to treat secon­
dary pustular follicles have been used. In severe cases, acne 
surgery or dermabrasion may be effective.
Ü
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(10) What is likely to be the cause of the child’s rash and other symptoms mentioned in the case study? 
What treatment will you recommend?
Standards and Regulations
Before 1965, it was not uncommon for TCDD to be present as a 
product contaminant in herbicides at concentrations exceeding 
30 mg/kg (30 ppm). Today, however, the concentration of TCDD as 
a product contaminant is limited to 0.01 to 0.05 ppm.
Workplace
Air
□  OSHA has not set a No permissible exposure limit (PEL) has been set for dioxin by the
workplace standard for Occupational Safety and Health Administration (OSHA), which is
dioxins. responsible for workplace standards. NIOSH considers TCDD a
“probable" human carcinogen and recommends that workplace 





EPA currently has no standard for TCDD or other dloxlns in ambient 
air.
Water
The EPA has set a maximum contaminant level forTCDD in drinking 
water of 5 x 10'8 mg/L, or 0.05 ppt. A maximum contaminant level 
goal of zero will be proposed by EPA in June 1990.
Food
Fish is the greatest potential food source of dioxin contamination. 
Dioxins readily adsorb to aquatic sediment, and can be ingested by 
bottom-feeding organisms that are subsequently ingested by preda- 
toryfish, thereby bioconcentrating these substances. The U.S. Food 
and Drug Administration's (FDA) limit for dioxins in fish is 25 ppt 
TCDD. Since livestock are herbivores, the dioxin bioconcentration 
potential in these mammals is minimal unless they are grazing on 
contaminated pasture. There are no standards for meats or other 
foodstuffs.
□  Dioxins in ambient air are not 
currently regulated.
□  The legal level for TCDD In 
drinking water Is 0.05 ppt
□  Fish Is the only food regu 
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Answers to Pretest and Challenge Questions
Pretest is found on page 1. Challenge questions begin on page 4.
(1) A call to the medical director or the health and safety department of the utility company should provide the 
answer to the type of herbicide used and its contents. Dioxin-containing herbicides are not likely to have 
been used in this case since they are no longer being manufactured in the United States.
(2) The patient could be at increased risk of dioxin exposure because he is living in an area of possible soil 
contamination. Normal hand-to-mouth activity of children can result in ingestion of contaminated soil. 
Because of the child's age, it is unlikely that he has pica (the abnormal ingestion of nonfood items, commonly 
found in children aged 2 to 6 years), which could significantly increase the boy’s soil intake. Children 
consume large quantities of milk, which can be a source of dioxins if it comes from cows grazing on 
contaminated vegetation. The small amount of dioxin leached from paper milk cartons is negligible.
If the family raises its own foodstuffs and if the previous owner of the farm used contaminated herbicides 
that still may be present in the soil, the current root crops could contain small amounts of dioxins. (Evidence 
for translocation of dioxins is sparse and inconclusive.) Even though production of herbicides such as 
2,4,5-T were discontinued in the United States in 1976, the half-life of dioxin in soil may be 10 years or more, 
depending on the type of soil. However, this source is likely to be insignificant in terms of health risk.
(3) Even if the herbicide did contain dioxins, these compounds photodegrade rapidly, resulting in a half-life on 
vegetation of several hours and several days in air. The half-life of dioxins in surface soil is 1 to 3 years, while 
dioxins beneath the soil surface could have a half-life of 10 years or more. However, dermal absorption from 
TCDD-contaminated soil is less than 5%. If the children do not ingest the soil, the danger is minimal.
(4) The primary human health effects of dioxin exposure are chloracne, and secondarily, hepatomegaly, 
elevated liver enzyme levels, and possibly peripheral neuropathy (subclinical changes in nerve conduction 
velocity).
(5) Although dioxins are proven carcinogens in some animals, their carcinogenic effect in humans requires 
further study. Even if the herbicide contained TCDD, the risk of cancer for this patient is likely to be 
insignificant from a one-time exposure that caused no acute effects.
(6) Some of the issues you might address in obtaining the medical history are the following: the type and extent 
of farming carried on by the family: their lifestyle before coming to this farm; dietary habits, including present 
or past pica in the child.
(7) During the physical examination, the skin should be carefully examined for evidence of rash, particularly 
chloracne. Chloracne is a papular, sometimes pustular, lesion located principally on the upper facial areas. 
The onset of chloracne is not acute, as was the rash described in the case study. In addition, an examination 
of the abdomen should be conducted, looking for hepatomegaly or hepatic tenderness. A neurologic 
examination might also be undertaken, with a mental status examination to assess more subtle CNS effects.
(8) Analytical tests for TCDD (adipose tissue, serum) are very specialized and expensive, and generally are not 
recommended in clinical practice, especially since interpretation in individual cases is difficult. Dioxins may 
be associated with hepatotoxicity, and liver function tests would be appropriate if there has been known 
exposure to dioxin.
(9) Symptoms associated with acute exposure to dioxin-containing substances include skin and mucous 
membrane irritation, headache, fatigue, abdominal pain, memory and personality changes, and insomnia. 
However, such symptoms are nonspecific and may have other etiologies.
(10) The cause of the child’s rash is more likely to be poison ivy, which is common in the wooded areas of the 
Midwest, an allergy, or exposure to some chemical other than a dioxin. This conclusion is suggested by the 
acute onset of the rash, its appearance, and its burning nature. Referral to a dermatologist may be warranted 
if standard measures of treating the rash are not efficacious. The child’s symptoms of headache and 
stomachache may be a result of such factors as stress, food intolerance, or viral infection. If symptoms do 




More information on the adverse effects of dioxins and the treatment and management of dioxin-exposed 
persons can be obtained from ATSDR, your state and local health departments, and university medical 
centers. Case Studies in Environmental Medicine: Dioxin Toxicity is one of a series. For other publications 
in this series, please use the order form on the back cover. For clinical inquiries, contact ATSDR, Division 
of Health Education, Office of Director, at (404) 639-6204.
Posttest
Continuing education credit is available to health professionals who use this monograph and complete the 
posttest. The criterion for awarding CME credits and CEUs is a posttest score of 70% or better.
The Centers for Disease Control (CDC) is accredited by the Accreditation Council for Continuing Medical Education 
(ACCME) to sponsor continuing medical education for physicians, and by the International Association for 
Continuing Education and Training (IACET) to sponsor continuing education units for other health professionals.
The Agency for Toxic Substances and Disease Registry, in joint sponsorship with CDC, is offering 1 credit hour 
of continuing medical education (CME) credit in category 1 of the Physician's Recognition Award of the American 
Medical Association and 0.1 hour of continuing education units (CEU) for other health professionals upon 
completion of this monograph.
This program has been reviewed and is acceptable for 1 prescribed hour by the American Academy of Family 
Physicians (term of approval: beginning January 1992). For specific information, please consult the AAFP Office 
of Continuing Medical Education.
The American College of Emergency Physicians (ACEP) has approved this program for 1 hourof ACEP Category 
1 credit.
The American Osteopathic Association (AOA) has approved this program for 1 credit hour of Category 2-B AOA- 
CME credit.
To receive continuing education credit (CME or CEUs), complete the Posttest on page 26 in the manner shown 
in the sample question below. Circle all correct answers.
Which of the following is known to precipitate migraine headaches?
f fatigue alcohol grapefruit 
(3}sunlight 
e. sleep
After you have finished the Posttest, please transfer your answers to the answer sheet on the inside back cover 
and complete the evaluation on the lower half of that page. Fold, staple, and mail the back cover to Continuing 
Education Coordinator, Agency for Toxic Substances and Disease Registry, Division of Health Education, E33, 
1600 Clifton Road, Atlanta, GA 30333. Your confidential test score will be returned with an indication of where 
the correct answers can be found in the text. Validation of earned CME credit and CEUs will also be forwarded 
to participants, and their names, if requested, will be placed on the mailing list to receive other issues in the Case 




Circle all correct answers and transfer your answers to page 19.
1. Persons who may have had an increased risk of exposure to TCDD include
a. pesticide applicators




2. Levels of TCDD in adipose tissue
a. reflect dioxin exposure only within the past year
b. are decreased as a result of lactation
c. are related to blood TCDD levels
d. can be used as a means to determine body burden of TCDD
e. are likely to be elevated in patients with pancreatitis





e. food chain (fish, meat, milk)












6. Appropriate laboratory tests to monitor a patient with a dioxin exposure might include
a. ECG
b. thyroid function tests
c. CPK isoenzymes
d. T-cell function
e. liver function tests
7. Characteristics of the chloracne rash seen after TCDD exposure are
a. spontaneous resolution over 3 to 4 days
b. eruption of small, pale yellow cysts
c. nose, hands, and feet are commonly involved
d. short courses of topical corticosteroids always hasten resolution
e. the face is commonly involved
8. Laboratory tests that can confirm TCDD exposure include
a. T4:T8 ratio > 1.0
b. 24-hour urinary TCDD excretion normalized for creatinine excretion
c. GC-MS analysis for TCDD in serum or adipose tissue
d. HPLC analysis for TCDD in hair
e. TCDD-stimulated lymphocyte transformation testing
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If you wish CME credits or CEUs, please indicate your answers to the Posttest questions on page 18 by circling 
the letters below for the correct answers. Complete the evaluation questionnaire and fill in the information 
requested on the reverse side. Tear off this last page, fold, staple, and mail to Continuing Education Coordinator, 
Agency for Toxic Substances and Disease Registry, Division of Health Education, E33,1600 Clifton Road, Atlanta, 
GA 30333.
1. a b c d e
2. a b c d e
3. a b c d e
4. a b c d e
5. a b c d e
6. a b c d e
7. a b c d e
8. a b c d e
Evaluation Questionnaire
Please complete the following evaluation by circling your response.
1. Was the breadth of information in this issue sufficient for your needs?
Yes No Undecided
2. Was the amount of detail appropriate?
Too technical Just right Not technical enough
3. As a result of reading this issue, will you now ask patients more questions regarding possible 
environmental exposures?
Yes No Undecided Not applicable
4. Would you recommend this issue to your colleagues?
Yes No Undecided




To obtain credit, please provide the requested information below.
Name
Address
--------------------------------------------------------------  Z ip --------------------------------
Check one:
□  CME-AMA □  CME □  CME-ACEP □  CME-AOA
I I CEU □  Contact Hours
Specialty__________________________________________________







Agency for Toxic Substances and Disease Registry 
Division of Health Education, E33 
1600 Clifton Road, NE 
Atlanta, GA 30333
fold here second
Circle the Case Studies in Environmental Medicine that you wish to have sent to you.
□ arsenic □  dioxins □ tetrachloroethylene
□ asbestos □  lead □ 1,1,1-trichloroethane
□ benzene □  mercury □ trichloroethylene
□ beryllium □  methanol □ toluene
□ cadmium Q  methylene chloride □ vinyl chloride
□ carbon tetrachloride □  nitrates/nitrites □ Exposure History
□ chlordane Q  phenols □ Risk Communication
□ Cholinesterase inhibitors □  polyaromatic hydrocarbons (PAHs) □ Skin Diseases
□ chromium □  polychlorinated biphenyls (PCBs)
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The state of knowledge regarding the treatment of patients potentially 
exposed to hazardous substances in the environment is constantly evolving 
and is often uncertain. In this monograph, the Agency for Toxic Substances 
and Disease Registry (ATSDR) has made diligent effort to ensure the 
accuracy and currency of the information presented but makes no claim that 
the document comprehensively addresses all possible situations related to 
this substance. This monograph is intended as an additional resource for 
physicians and other health professionals in assessing the condition and 
managing the treatment of patients potentially exposed to hazardous sub­
stances. It is not, however, a substitute for the professional judgment of a 
health care provider and must be interpreted in light of specific information 
regarding the patient available to such a professional and in conjunction with 
other sources of authority.
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